Clinical Trials Browser

Phase 2 × OTHER_GOV × ARX788 × Clear all

NCT06663748 2024-10-29

ARX788 in HER2-positive Metastatic Breast Cancer Patients

Phase 2 Not yet recruiting

Breast Neoplasms